Balyasny Asset Management L.P. 13D and 13G filings for Avalo Therapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2025-11-14 06:01 am Purchase | 2025-09-30 | 13G | Avalo Therapeutics, Inc. AVTX | Balyasny Asset Management L.P. | 817,436 6.220% | 817,436 (New Position) | Filing |